VIRMA and breast cancer: In breast cancer, KIAA1429 promotes the epithelial–mesenchymal transition (EMT) by increasing SMC1A (structural maintenance of chromosomes 1A) expression in an m6A modification-dependent manner, and indirectly promoting SNAIL (Snail family transcriptional repressor 1) expression [5].